This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Federal Trade Commission (FTC) and Department of Justice (DOJ), Antitrust Division announced that they will hold three workshops regarding their jointly issued Draft Merger Guidelines. The first virtual workshop will be held on September 5, at 1-4:15 p.m. By: Troutman Pepper
Earlier this week, the Federal Trade Commission and the Department of Justice announced that they will be co-hosting three workshops to facilitate public dialogue on the recently issued draft Merger Guidelines. The first of these workshops will take place this coming Tuesday, September 5, from 1 p.m. to 4:15 p.m.
On March 5, the Federal Trade Commission (FTC) hosted a public workshop titled “Private Capital, Public Impact: An FTC Workshop on Private Equity in Health Care.” The event is part of the agency’s effort to publicize and encourage enforcement targeting private equity investments in health care.
The Federal Trade Commission, in coordination with the U.S. Department of Justice Antitrust Division, recently released a summary of the Agencies’ June 2022 joint workshop titled “The Future of Pharmaceuticals: Examining the Analysis of Pharmaceutical Mergers.” By: Mintz
Earlier this week, the Department of Justice (“DOJ”) and Federal Trade Commission (“FTC”) released the long-awaited 2023 Merger Guidelines. The final guidelines are the result of nearly two years of behind-the-scenes drafting, numerous public listening sessions and workshops, and the receipt of some 35,000 public comments.
On September 5, 2023 the Federal Trade Commission (FTC) and Department of Justice (DOJ) (the Agencies) hosted the first of three planned workshops intended to “facilitate public dialogue” on the 2023 FTC and DOJ Draft Merger Guidelines (the draft guidelines). If adopted, the guidelines would memorialize the Agencies’.
On June 1, 2023, the Federal Trade Commission (FTC) and the Antitrust Division of the US Department of Justice (DOJ) released a summary of a workshop jointly held by the agencies in June 2022 titled “Future of Pharmaceuticals: Examining the Analysis of Pharmaceutical Mergers.” By: Hogan Lovells
On December 18, 2023, the Department of Justice (“DOJ”) and the Federal Trade Commission (“FTC”) (collectively, the “Agencies”) released the 2023 Merger Guidelines (the “Guidelines”), which are the result of a two-year process that involved the Agencies soliciting feedback from the public and staff, including responses to draft merger guidelines, and (..)
On March 5, 2024, the Federal Trade Commission (FTC) hosted a public workshop to “examine the role of private equity investment in health care markets” (the FTC workshop). Private equity investment in the health care sector continues to be a significant area of focus for the U.S. antitrust agencies.
Outside of IB, various asset managers, hedge funds, consulting firms, and trading firms also run some type of spring week program, but we’re focusing on banking here. Attending workshops and training sessions. The rates trading article has some tips for S&T assessment centers and interviews.
By following the steps given to this prompt and tailoring them to your organization’s unique needs, you can develop a comprehensive M&A playbook that will help guide your company through successful mergers and acquisitions. Vertical mergers: Acquiring companies along your supply chain to secure resources or distribution channels.
Mr. Bicksler’s experience providing strategic merger and acquisition consulting services also comes from his former role as a Principal of Catalina Consulting during which he was responsible for evaluating numerous companies on behalf of private investment firms. It’s also important to attend workshops and trade shows like Photonics West.
Novartis announced plans to spin off its generics and biosimilars division into a publicly traded stand-alone company. With new general merger guidelines anticipated in 2023, companies should expect to see more from the agencies pushing the boundaries of traditional antitrust enforcement.
The agencies took a more measured approach on March 5, 2024, when the Federal Trade Commission (FTC) hosted a public workshop to examine the role of private equity investment in the healthcare industry. 21, 2023, lawsuit challenging one private equity firm's "roll-up" of anesthesiology practices in Texas. By: Holland & Knight LLP
As part of the Biden administration’s State of the Union blitz, the Federal Trade Commission (FTC) convened a workshop on private equity (PE) investments in the health care industry on March 5, 2024.
Earlier this year, the Federal Trade Commission (FTC) and Department of Justice Antitrust Division (DOJ) held workshops focusing on PE’s role in health care. Private Equity (PE) has been a popular and frequent target of the Biden Administration’s recent antitrust enforcement efforts. By: Stinson LLP
With a team of progressives filling leadership roles at the Federal Trade Commission and in the Antitrust Division of the US Department of Justice, companies are able to predict what the next several years may look like. Increasing procedural hurdles to merger review. New obstacles to the merger review process are significant.
We organize all of the trending information in your field so you don't have to. Join 38,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content